TH and Alzheimer disease: Considering this, and with the PD model being validated, we showed that 1 mg/kg of AD-16 given orally daily for 7 days after the model onset conferred neuroprotection, by reducing TH loss in both the SNc and the striatum, in addition of alleviating motor impairment.